Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remotely Controlled Intervention for Developmental Reading and Spelling Disorders

NCT04382482 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT04382482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remotely Controlled Intervention for Developmental Reading and Spelling Disorders
Lead sponsor
IRCCS Eugenio Medea
Phase
Observational
Overall status
Completed
Start date
January 20, 2018
Completion date
January 30, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

developmental dyslexia, developmental spelling disorder